相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vector-mediated release of GABA attenuates pain-related behaviors and reduces NaV1.7 in DRG neurons
Munmun Chattopadhyay et al.
EUROPEAN JOURNAL OF PAIN (2011)
Central sensitization: Implications for the diagnosis and treatment of pain
Clifford J. Woolf
PAIN (2011)
The evidence for pharmacological treatment of neuropathic pain
Nanna Brix Finnerup et al.
PAIN (2010)
Effects of transgene-mediated endomorphin-2 in inflammatory pain
Shuanglin Hao et al.
EUROPEAN JOURNAL OF PAIN (2009)
Applications of gene therapy to the treatment of chronic pain
Marina Mata et al.
CURRENT GENE THERAPY (2008)
Continuous δ-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy
Munmun Chattopadhyay et al.
JOURNAL OF NEUROSCIENCE (2008)
Adverse effects of transdermal opiates treating moderate-severe cancer pain in comparison to long-acting morphine: A meta-analysis and systematic review of the literature
Davide Tassinari et al.
JOURNAL OF PALLIATIVE MEDICINE (2008)
On the thermo regulatory perils of TRPV1 antagonism
Michael J. Caterina
PAIN (2008)
Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
Narender R. Gavva et al.
PAIN (2008)
Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain
Benjamin Storek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Engineering an endomorphin-2 gene for use in neuropathic pain therapy
Darren Wolfe et al.
PAIN (2007)
Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer
M. Chattopadhyay et al.
DIABETOLOGIA (2007)
Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials
Jan Magnus Bjordal et al.
EUROPEAN JOURNAL OF PAIN (2007)
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain
Erin D. Milligan et al.
PAIN (2006)
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjects
G de Bruyn et al.
VACCINE (2006)
Gene transfer of glutamic acid decarboxylase reduces neuropathic pain
SG Hao et al.
ANNALS OF NEUROLOGY (2005)
Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy
M Chattopadhyay et al.
BRAIN (2004)
Opioids in chronic non-cancer pain: systematic review of efficacy and safety
E Kalso et al.
PAIN (2004)
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain
J Liu et al.
MOLECULAR THERAPY (2004)
Intratumoral injection of herpes simplex virus HF10 in recurrent breast cancer
A Nakao et al.
ANNALS OF ONCOLOGY (2004)
HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival
S Harrow et al.
GENE THERAPY (2004)
Herpes vector-mediated gene transfer in treatment of diseases of the nervous system
JC Glorioso et al.
ANNUAL REVIEW OF MICROBIOLOGY (2004)
Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain
SL Hao et al.
PAIN (2003)
Herpes vector-mediated expression of proenkephalin reduces bone cancer pain
JR Goss et al.
ANNALS OF NEUROLOGY (2002)
The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study
V Papanastassiou et al.
GENE THERAPY (2002)
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3
M Chattopadhyay et al.
ANNALS OF NEUROLOGY (2002)
Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal roof ganglion
JR Goss et al.
GENE THERAPY (2001)
Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma
R Rampling et al.
GENE THERAPY (2000)
Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial
JM Markert et al.
GENE THERAPY (2000)
分享论文
